Amended Statement of Ownership (sc 13g/a)

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

____________________

Schedule 13G/A

Under the Securities Exchange Act of 1934

(Amendment 1 )

____________________

  Medican Enterprises Inc.

(Name of Issuer)

 

____________________

Common Stock

(Title of Class of Securities)

58464T202

(CUSIP Number)

October 31, 2016

(Date of Event Which Requires Filing of this Statement)

  ____________________

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

x Rule 13d-1(b)

¨ Rule 13d-1(c)

¨ Rule 13d-1(d)

 

*		The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

---

SCHEDULE 13G/A

CUSIP No.			58464T202
1.		Name of reporting person I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (entities only) KCG Americas LLC 26-4219373
2.		CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)   ¨          (b)   ¨
3.		SEC Use only
4.		Citizenship or place of organization           Delaware
Number of shares beneficially owned by each reporting person with				5.		Sole voting power
						704,403
				6.		Shared voting power        Not applicable
				7.		Sole dispositive power
						704,403
				8.		Shared dispositive power       Not applicable
9.		Aggregate amount beneficially owned by each reporting person
		704,403
10.		Check box if the aggregate amount in Row (9) excludes certain shares* ¨
11.		Percent of class represented by amount in Row 9
		0.52%				based on outstanding shares reported on the issuer's 10-Q filed with the SEC for the period ended March 31, 2015.
12.		Type of reporting person*        BD

---

ITEM 1	(a).		Name of Issuer
			Medican Enterprises Inc.
ITEM 1	(b).		Address of Issuer’s Principal Executive Offices
			3440 East Russell Road, Las Vegas, NV 89120
ITEM 2	(a).		Names of Persons Filing
			KCG Americas LLC
ITEM 2	(b).		Address of principal business office
			545 Washington Blvd., Jersey City, NJ 07310
ITEM 2	(c).		Citizenship
			Delaware
ITEM 2	(d).		Title of Class of Securities
			Common Stock
ITEM 2	(e).		CUSIP Number
			58464T202
ITEM 3.	If this statement is filed pursuant to Rules 13d-1(b), or 13(d)-2(b), check whether the person filing it is a:
	(a)		x	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

---

ITEM 4.	Ownership
(a)		Amount beneficially owned
		704,403
(b)		Percent of class
		0.52 %
(c)		Number of shares as to which such person has:
		(i)	sole power to vote or to direct the vote
			704,403
		(ii)	shared power to vote or to direct the vote
			Not applicable
		(iii)	sole power to dispose or to direct the disposition of
			704,403
		(iv)	shared power to dispose or to direct the disposition of
			Not applicable
ITEM 5.	Ownership of Five Percent or Less of a Class
Not applicable
ITEM 6.	Ownership of More than Five Percent on Behalf of Another Person
Not applicable
ITEM 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company
Not applicable.
ITEM 8.	Identification and Classification of Members of the Group
Not applicable.
ITEM 9.	Notice of Dissolution of Group
Not applicable.
ITEM 10.	Certification
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: November 10, 2016

 

KCG Americas LLC
By:		/s/ Christy Oeth
		Christy Oeth
		Chief Compliance Officer